A two-period cross-over study assessing Impact of Meal Timing on Eravacycline Exposure During the Oral Portion of an IV to Oral Transition Dosing Regimen

Trial Profile

A two-period cross-over study assessing Impact of Meal Timing on Eravacycline Exposure During the Oral Portion of an IV to Oral Transition Dosing Regimen

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Oct 2017

At a glance

  • Drugs Eravacycline (Primary) ; Eravacycline (Primary)
  • Indications Intra-abdominal infections; Respiratory tract infections; Urinary tract infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 23 Oct 2017 New trial record
    • 08 Oct 2017 Results presented at the IDWeek 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top